Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Mar. 31, 2021
Current assets:
Cash and cash equivalents	$ 268,695	$ 240,821
Short-term investments	559,984	575,254
Accounts receivable, net of allowances of $3,073 and $2,633, respectively	226,182	174,027
Prepaid expenses and other current assets	29,447	21,944
Deferred contract acquisition costs	24,058	36,210
Total current assets	1,108,366	1,048,256
Property and equipment, net	68,368	91,308
Restricted cash	5,775	5,642
Goodwill	163,677	144,253
Intangible assets, net	15,636	12,986
Deferred contract acquisition costs, non-current	10,463	32,579
Lease right-of-use assets	50,465	57,425
Other assets, non-current	4,916	6,170
Total assets	1,427,666	1,398,619
Current liabilities:
Accounts payable	32,545	24,171
Accrued compensation and benefits	37,023	37,196
Other current liabilities	36,098	19,174
Deferred revenue	398,754	373,594
Lease liabilities	11,103	7,886
Total current liabilities	515,523	462,021
Convertible senior notes, net	497,663	449,380
Lease liabilities, non-current	49,809	59,924
Deferred revenue, non-current	108	1,674
Other liabilities, non-current	20,173	8,256
Total liabilities	1,083,276	981,255
Redeemable non-controlling interest	21,686	3,389
Stockholders’ equity:
Common stock, $0.001 par value; 100,000 shares authorized at March 31, 2022 and March 31, 2021; 66,988 shares and 64,019 shares issued at March 31, 2022 and March 31, 2021; and 66,728 shares and 63,759 shares outstanding at March 31, 2022 and March 31, 2021	66	64
Treasury stock—at cost (260 shares)	(263)	(263)
Additional paid-in capital	1,114,221	1,001,309
Accumulated other comprehensive loss	(8,012)	(19)
Accumulated deficit	(783,308)	(587,116)
Total stockholders’ equity	322,704	413,975
Total liabilities, redeemable non-controlling interest and stockholders’ equity	$ 1,427,666	$ 1,398,619